Find trials
Search tips

FDA approved Computer-assisted Trans-perineal/Trans-rectal Prostate Biopsy Devices With and Without MRI U/S Fusion

Overview

About this study

The purpose of ths study is to evaluate and compare the performance characteristics of the available FDA approved transperineal biopsy devices.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • All patients undergoing TRUS guided biopsies of the prostate at the Gonda Outpatient Procedure Center (OPC) will be eligible for consenting to this study.  

Exclusion Criteria:

  • Patients not qualified for the above criteria.

Eligibility last updated 5/24/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Lance Mynderse, M.D.

Contact us for the latest status

Contact information:

Wendy Sundt CCRP

(507) 293-4234

Sundt.Wendy@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20551774

Mayo Clinic Footer